Regeneron Pharmaceuticals Market Cap

Regeneron Pharmaceuticals has a market cap or net worth of €58.26 billion as of November 7, 2025. Its market cap has decreased by -38.18% in one year.

Market Cap

58.26B

Enterprise Value

44.42B

Revenue

12.14B

Ranking

n/a

PE Ratio

14.93

Stock Price

€558.00

Market Cap Chart

Since July 20, 1992, Regeneron Pharmaceuticals's market cap has increased from 131.41M to 58.26B, an increase of 44,234.54%. That is a compound annual growth rate of 20.07%.

Market Cap History

Date	Market Cap	% Change
Nov 7, 2025	58.26B	-21.30%
Dec 31, 2024	74.03B	-12.40%
Dec 29, 2023	84.50B	17.20%
Dec 30, 2022	72.10B	24.19%
Dec 31, 2021	58.06B	39.28%
Dec 31, 2020	41.68B	13.96%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	251.15B
Siemens Aktiengesellschaft	183.79B
Allianz SE	133.88B
Deutsche Telekom AG	127.09B
Siemens Energy AG	86.73B
Rheinmetall AG	80.25B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	68.66B
Deutsche Bank Aktiengesellschaft	59.27B

Market Cap Rankings